Protecting youth from the vaping epidemic.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
11 2020
Historique:
received: 22 07 2020
revised: 07 08 2020
accepted: 11 08 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 19 8 2021
Statut: ppublish

Résumé

E-cigarettes (e-cigs) have been initially proposed as an aid to smoke cessation in adults, whereas they turned into a paradoxical preferential gateway to tobacco and nicotine initiation for adolescents naïve to tobacco. More than 25% of US school-age students is an e-cigs user with a steep rise over the past years. A marketing strategy on media and social network targeting youths, in the absence of rules to protect the pediatric users, resulted in an unprecedented trend up in tobacco consumption among adolescents and gave rise to a new generation of nicotine-addicted teenagers. Flavored e-cigs liquids and aerosols contain airway irritants and toxicants, that, in turn, produced an increase in asthma prevalence and its exacerbations among adolescents. In addition, since August 2019 an outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) has been described. In view of this, e-cigs must no longer be considered harmless, especially in adolescents never used a tobacco product before. This is a call-for-action to establish effective rules and campaigns targeting youths aimed to limit their access to e-cigs, thereby preserving the potential benefit in quitting tobacco addiction described in adults. Behavioral and educational actions, out of the conventional primary care setting, have been described as a model for a youth-centered campaign. We call for stricter regulations on e-cigs products, with respect to their marketing to the youngest ones, along with public health and primary care interventions that could curb the spread of this "vaping" epidemic.

Identifiants

pubmed: 33236441
doi: 10.1111/pai.13348
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-68

Informations de copyright

© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Références

Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629-637.
Chadi N, Schroeder R, Jensen JW, Levy S. Association between electronic cigarette use and marijuana use among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2019;12:e192574.
Ferrara P, Franceschini G, Corsello G, et al. The health risks of electronic cigarettes use in adolescents. J Pediatr. 2020;219: 286-287.e3.
Cullen KA, Liu ST, Bernat JK, et al. Flavored tobacco product use among middle and high school students - United States, 2014-2018. MMWR Morb Mortal Wkly Rep. 2019;68(39):839-844.
Clapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17(11):79.
McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195(8):1043-1049.
Ghosh A, Coakley RD, Ghio AJ, et al. Chronic E-cigarette use increases neutrophil elastase and matrix metalloprotease levels in the lung. Am J Respir Crit Care Med. 2019;200(11):1392-1401.
Werner AK, Koumans EH, Chatham-Stephens K, et al. Hospitalizations and deaths associated with EVALI. N Engl J Med. 2020;382(17):1589-1598.
Carroll BJ, Kim M, Hemyari A, et al. Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents. Pediatr Pulmonol. 2020;55(7):1712-1718. https://doi.org/10.1002/ppul.24787
Io non me la fumo. Multimedial project for school against tobacco smoke and e-cigarettes. Department of Women’s and Children’s Health and Department of Developmental and Socialization Psychology, University of Padua. Museum of History of Medicine. 26th November 2019.

Auteurs

Alfonso Galderisi (A)

Department of Woman and Child's Health, University of Padova, Padova, Italy.

Valentina Agnese Ferraro (VA)

Department of Woman and Child's Health, University of Padova, Padova, Italy.

Marta Caserotti (M)

Department of Developmental and Socialization Psychology, University of Padova, Padova, Italy.

Luca Quareni (L)

MUSME (Museum of History of Medicine), Padova, Italy.

Giorgio Perilongo (G)

Department of Woman and Child's Health, University of Padova, Padova, Italy.

Eugenio Baraldi (E)

Department of Woman and Child's Health, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH